Cargando…
Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study
We aimed to explore the medium- and long-term (≥12 weeks) effects of dapagliflozin on serum uric acid (SUA) level in patients with type 2 diabetes mellitus (T2DM) in the real world study and to explore the influencing factors of dapagliflozin on reducing SUA level. This observational, prospective co...
Autores principales: | Wang, Shihan, Yuan, Tao, Song, Shuoning, Duo, Yanbei, Zhao, Tianyi, Gao, Junxiang, Fu, Yong, Dong, Yingyue, Zhao, Weigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861887/ https://www.ncbi.nlm.nih.gov/pubmed/36675682 http://dx.doi.org/10.3390/jpm13010021 |
Ejemplares similares
-
Patterns of Insulin Secretion During First-Phase Insulin Secretion in Normal Chinese Adults
por: Yuan, Tao, et al.
Publicado: (2021) -
Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial
por: Yuan, Tao, et al.
Publicado: (2020) -
Diabetes management in patients undergoing total pancreatectomy: A single center cohort study
por: Zhao, Tianyi, et al.
Publicado: (2023) -
Effect of sodium‐glucose cotransporter 2 inhibitors on the rate of decline in kidney function: A systematic review and meta‐analysis
por: Duo, Yanbei, et al.
Publicado: (2023) -
The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
por: Iwata, Yukimasa, et al.
Publicado: (2023)